university website

J.N. van den Anker (John) and K.M. Allegaert (Karel)

2012

Clinical pharmacology in neonates and young infants

Publication

Publication

The benefit of a population-tailored approach

Expert Review of Clinical Pharmacology , Volume 5 - Issue 1 p. 5- 8

Additional Metadata
Keywords biomarker, developmental pharmacology, infant, neonate, pharmacodynamics, pharmacokinetics
Persistent URL doi.org/10.1586/ecp.11.65, hdl.handle.net/1765/31998
Journal Expert Review of Clinical Pharmacology
Grant This work was funded by the European Commission 7th Framework Programme; grant id fp7/223614 - Evaluation of antibiotics (ciprofloxacin and fluconazole) for the treatment of infections in preterm and term neonates (TINN), This work was funded by the European Commission 7th Framework Programme; grant id fp7/260908 - Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates (TINN2), This work was funded by the European Commission 7th Framework Programme; grant id fp7/223060 - Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia (NEUROSIS)
Organisation Erasmus MC: University Medical Center Rotterdam
Citation
van den Anker, J.& Allegaert, K. (2012). Clinical pharmacology in neonates and young infants: The benefit of a population-tailored approach. In Expert Review of Clinical Pharmacology (Vol. 5, Number 1, pp. 5–8).https://doi.org/10.1586/ecp.11.65


User Publication Person Organisation Collection
Close